Kyle, your ardor and enthusiasm is so passionate that I'm forced to respond. I've been in and out of this stock since 2011, when it traded from .21 to over .70 cents a share. I know these people and this company better than you. I know this product as well.
All of your medical facts are correct. I know this because, since April of 2011, I've also done extensive research on the positive aspects of natural organic homeopathic migraine medications, including the feverfew and ginger effectiveness offered by PuraMed's Lipigesic M.
There's only one problem. Lipigesic M doesn't sell, but to a very few individuals who care about such things. For all of your rantings, your're still unaware of the fact that Russ Mitchell and Jim Higgins can't sell this product to the major retailers who offer these alternative medications, which include Target, Walmart, Walgreen's, Whole Foods, GNC, Trader Joes, and other retailers. Those people are not buying it.
What you must know is that most Americans who suffer from Acute Migraines, don't really care about homeopathic alternatives. They don't want to pay $21,00 for six (6) sublingual gel tablets. They ARE Willing to pay $8 or 9$ for 100 Excedrin or Tylenol Migraine tablets, regardless of the negative aspects of those products. Remember, these are overweight, under nourished Americans. You know, morons. Most people only care about 1.) Does it work, and 2.) How much does it cost?
Once you get clear on how and what "consumers" think and want, then you'll finally get why Excedrin Migraine sells and Lipigesic M doesn't. All the rest is just dialogue about a product and a company's stock that sells for 3 tenths of a cent. It's just that simple.
Unless something drastically changes or a new product appears that DOES sell, then nothing much will happen.
And finally, remember, HOPE is not a strategy when trading stocks. Only facts matter.
News 
Market Data 
Discover 
AI
